Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)

OBJECTIVE: To examine the efficacy and safety of adding the once-daily glucagon-like peptide-1 receptor agonist (GLP-1RA) lixisenatide to established basal insulin therapy alone or together with metformin, in people with type 2 diabetes and elevated glycated hemoglobin (HbA(1c)). RESEARCH DESIGN AND...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Riddle, Matthew C., Aronson, Ronnie, Home, Philip, Marre, Michel, Niemoeller, Elisabeth, Miossec, Patrick, Ping, Lin, Ye, Jenny, Rosenstock, Julio
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747925/
https://ncbi.nlm.nih.gov/pubmed/23628617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2454
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares